Zealand Pharma A/S (FRA:22Z)

Germany · Delayed Price · Currency is EUR

50.74

-0.76 (-1.48%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	9.21B	62.69M	342.79M	103.99M	108.55M
Biotechnology Growth	14598.86%	-81.71%	229.65%	-4.20%	-43.47%
Total	9.21B	62.69M	342.79M	103.99M	108.55M
Total Growth	14598.86%	-81.71%	229.65%	-4.20%	-43.47%

Revenue by Geography

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Denmark	34.90M	62.29M	44.19M	34.96M	-
Denmark Growth	-43.98%	40.96%	26.39%	-	-
Switzerland	9.18B	-	-	-	-
United States	-	406.00K	4.09M	69.03M	55.50M
United States Growth	-	-90.08%	-94.07%	24.37%	29.37%
Germany	-	-	294.51M	-	53.00M
Germany Growth	-	-	-	-	-64.45%
Total	9.21B	62.69M	342.79M	103.99M	108.50M
Total Growth	14598.86%	-81.71%	229.65%	-4.16%	-43.49%

Source: S&P Global Market Intelligence.